Synthesis of new benzothienylpiperazine derivatives and their characterisation at both 5HT(1A) and 5HT(1B) receptor sites

Medicinal Chemistry Research

Volumn 8, Issue 3, 1998, Pages 132-142

  Lamothe, M ^a   Pauwels, P J ^a   Leborgne, M ^a   Halazy, S ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROBENZOYL)PIPERIDINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; PIPERAZINE DERIVATIVE; SEROTONIN RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CENTRAL NERVOUS SYSTEM FUNCTION; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; FEEDBACK SYSTEM; NEUROTRANSMITTER RELEASE; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; RECEPTOR AFFINITY; REGULATORY MECHANISM;

EID: 0031828009     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Glennon, R.A. Neurosci. Biobehav. Rev. 1990, 14, 34-47.
2. a. Waeber, C.; Schoeffter, P.; Hoyer, D.; Palacios, J. M. Neurochem. Res. 1990, 15, 567.
3. b. Fletcher, A.; Bill, D. J.; Bill, S. J.; Cliffe, I. A.; Dover, J. M.; Forster, E. A.; Haskins, J. T.; Jones, D.; Mansell, H. L.; Reilly, Y. Eur. J. Pharmacol. 1993, 237, 283.
4. Maes, M.; Meltzer, H. Y.; In: Psychopharmacology: The fourth generation of progress. Bloom F.E., Kupfer D.J. (Eds), Raven Press, New York (1995) 933.
5. Elkin, I.; Shea, T.; Watkins, J. T.; Imber, S. D.; Sotsky, S. M.; Collins, J. F.; Glass, D. R.; Pilkonis, P. A.; Leber, W. R.; Docherty, J. P.; Fiester, S. J.; Parloff, M. B. Arch. Gen. Psychiatry 1989, 46, 971.
6. Artigas, F. Trends Pharmacol. Sci. 1993, 14, 262.
7. Blier, P.; De Montigny, C.; Chaput, Y. J. Clin. Psychiatry 1987, 7, 245.
8. Briley, M.; Moret, C. Clin. Neuropharmacol. 1993, 16, 387-400.
9. Gobert, A.; Rivet, J.-M.; Cistarelli, L.; Millan, M. J. J. Neurochem. 1997, 68, 1159.
10. Halazy, S.; Lamothe, M.; Jorand-Lebrun, C. Exp. Opin. Ther. Pat. 1997, 7, 339-352.
11. Jorand-Lebrun, C.; Pauwels, P. J.; Palmier, C.; Chopin, P.; Moret, C.; Marien, M.; Halazy, S. Bioorg. Med. Chem. Lett. 1997, 7, 3183-3188.
12. Bernotas, R. C.; Cheng, H. C.; Sprouse, J. S.; Adams, G.; Ficorilli, J. V.; McCarty, D. R.; Senyah, Y. 25th National Medicinal Chemistry Symposium University of Michigan, Ann Arbor, June 18-22, 1996 poster presentation abstract 93.
13. Bernotas, R. C. Patent WO 9406789 1994.
14. Sunggak, K.; Jae, I. L.; Young, K. K. Tetrahedron Lett. 1984, 25, 4943.
15. Ghosh, A. K.; Duong, T. T.; McKee, S. P. Tetrahedron Lett. 1991, 32, 4251-4254.
16. Pauwels, P. J.; Palmier, C.; Wurch, T.; Colpaert, F. C. Naunyn-Schmiedeberg's Arch. Pharmacol. 1996, 353, 144-156.
17. Pauwels, P. J.; Van Gompel, P.; Leysen, J. E. Biochem. Pharmacol. 1993, 45, 375-383.
18. Pauwels, P. J.; Palmier, C.; Colpaert, F. C. Cell. Pharmacol. 1995, 2, 49-57.
19. Jorand-Lebrun, C.; Pauwels, P. J.; Palmier, C.; Moret, C.; Chopin, P.; Perez, M.; Marien, M.; Halazy, S. J. Med. Chem. 1997, 40, 3974-3978.
20. Morrow, A.L.; Creese, I. Mol. Pharmacol. 1986, 29, 321-330.
21. Mallard, N.J.; Tyacke, R.; Hudson, A.L.; Nutt, D.J. Brit. J. Pharmacol. 1991, 102, 221.
22. Nisnik, B.H.; Grigoriadis, D.E.; Pri-Bar, I; Buchman, O.; Seeman, P. Naunyn-Schmiedeberg's Arch Pharmacol. 1985, 329, 333-343.